BURLINGTON, Mass., May 1, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that an oral presentation on TSO (Trichuris suis ova or CNDO-201) will be presented at the 8th International Congress on Autoimmunity to be held May 9-13, 2012 at the Palacio de Exposiciones y Congresos de Granadain in Granada, Spain.
